EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The pentose phosphate pathway in immunotherapy

Rachel D Loo, John Blazeck iD

Journal of Leukocyte Biology · 2026

DOI: 10.1093/jleuko/qiag106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Rachel D Loo und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Atlanta, GA 30332, United States. Hauptthemen laut MEDLINE: Pentose Phosphate Pathway, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence has highlighted the influence of cellular metabolism on both cancer and T cell growth and survival, including in the context of adoptive cell immunotherapy. It is known that T cells heavily rely on glycolysis for cell proliferation and mediating effector functions. However, less is known about the role of the pentose phosphate pathway (PPP), a parallel metabolic pathway that produces antioxidant and biosynthetic precursors, toward regulating antitumor T cell function. In this review, we summarize the PPP's role as a time-dependent regulator of T cell activation and redox balance, and its association with improved functional capacity in exhausted T cells. We further highlight the contrasting role of the PPP for CD8+ and CD4+ T cell differentiation in guiding antitumor responses, as well as a unique connection in the glycogen-PPP axis to CD8+ memory T cells. Finally, we summarize global metabolic regulators that drive expression of PPP enzymes and discuss future avenues for immunotherapy that could take advantage of our current understanding of the PPP's role in T cell metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pentose Phosphate PathwayImmunotherapyNeoplasmsHumansAnimalsLymphocyte ActivationT-Cell ExhaustionCD8-Positive T-LymphocytesT-LymphocytesGlycolysis

Stichwörter der Autor:innen

T cellsantioxidantscancer immunotherapyglycolysispentose phosphate pathway

Autor:innen und Institutionen

  • School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Atlanta, GA 30332, United States.
  • Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, 315 Ferst Drive NW, Atlanta, GA 30332, United States.
  • Cancer Technology Innovation Center, Georgia Institute of Technology, 225 North Avenue NW, Atlanta, GA 30332, United States.
  • Georgia Immunoengineering Consortium, Emory University and Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, GA 30332, United States.
  • Winship Cancer Institute, Emory University, 1365 Clifton Road NE, Building C, Atlanta, GA 30332, United States.

ORCID-Profile: John Blazeck

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Loo, R. D., & Blazeck, J. (2026). The pentose phosphate pathway in immunotherapy. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag106

Vancouver

Loo RD, Blazeck J. The pentose phosphate pathway in immunotherapy. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag106

BibTeX
@article{Loo2026,
  author = {Loo, Rachel D and Blazeck, John},
  title = {The pentose phosphate pathway in immunotherapy},
  journal = {Journal of Leukocyte Biology},
  year = {2026},
  doi = {10.1093/jleuko/qiag106}
}
Kostenlos starten →